Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_assertion type Assertion NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_head.
- NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_assertion description "[Similarly, BRCA1 cancer-predisposing mutation (61Cys-Gly) abrogated the ability to both bind Ubc9 as well as inhibit ERalpha activity suggesting physiological significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_provenance.
- NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_assertion evidence source_evidence_literature NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_provenance.
- NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_assertion SIO_000772 19287951 NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_provenance.
- NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_assertion wasDerivedFrom befree-20150227 NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_provenance.
- NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_assertion wasGeneratedBy ECO_0000203 NP764765.RAClkSv1m0b8AifMPQhSBYN036XpBSHUDS_SQv_AIPfiM130_provenance.